Article Sidebar
Published:
Dec 6, 2024Keywords:
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Sokoto Journal of Medical Laboratory Science (SJMLS) is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The journal holds the copyright for all the published articles. The signed copyright form submitted by the authors is a publication agreement between the journal and the authors.
Main Article Content
Immuno-haematological indices in Multi-Drug resistant tuberculosis: Implications for prognosis
Abstract
Multi-Drug resistant tuberculosis (MDR-TB) is a serious form of tuberculosis (TB) that is resistant to at least two of the most effective TB drugs, isoniazid (INH) and rifampicin (RMP/RIF). MDR-TB presents a significant challenge in global healthcare. Early identification of patients with poor prognosis is crucial for optimizing treatment strategies. This review explores the potential of immunohaematological indices as prognostic markers in MDR-TB. This review delves into the alterations in various blood parameters, including cell counts, inflammatory markers, and immune cell subsets, associated with MDR-TB.
